New acne gel shows promise in large trial

NCT ID NCT07384208

Ongoing Symptom relief Sponsor: PPM Services S.A. Source: ClinicalTrials.gov ↗

First seen Feb 03, 2026 · Last updated Jun 19, 2026 · Updated 17 times

Summary

This Phase 3 trial tests a new gel (N-Acetyl-GED-0507-34-LEVO) applied once daily for 12 weeks to reduce acne lesions on the face and trunk. About 400 participants will be randomly assigned to receive either the active gel or a placebo. Researchers will measure changes in lesion counts and overall acne severity using a standard doctor rating scale.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Amicare Sp. z o.o. S.K.

Lodz, Poland
Azienda Ospedaliera Di Rilievo Nazionale Antonio Cardarelli

Naples, Italy
Azienda Ospedaliera di Padova

Padova, Italy
Azienda Ospedaliero Universitaria Policlinico G Rodolico San Marco Di Catania

Catania, Italy
Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico

Bologna, Italy
Azienda Ospedaliero-Universitaria Maggiore Della Carita

Novara, Italy
Azienda USL Toscana Centro

Prato, Italy
Centrum Badan Klinicznych Pi-House Sp. z o.o.

Gdansk, Poland
Centrum Medyczne Plejady Magdalena Celinska Loewenhoff Michal Zolnowski sp.k.

Krakow, Poland
Clinical Best Solutions Sp. z o.o. S.K.

Lublin, Poland
Etg Warszawa Sp. z o.o.

Warsaw, Poland
Etyka Osrodek Badan Klinicznych Tomasz Pesta S.K.A.

Olsztyn, Poland
Fondazione Luigi Maria Monti

Roma, Italy
Futuremeds Spain S.L.

Madrid, Spain
Hospital De La Santa Creu I Sant Pau

Barcelona, Spain
Hospital Santa Maria Della Misericordia

Perugia, Italy
Hospital Universitario 12 De Octubre

Madrid, Spain
Hospital Universitario Fundacion Alcorcon

Alcorcón, Spain
Hospital Universitario Virgen De Las Nieves

Granada, Spain
Instituto Medico Ricart Valencia S.L.

Valencia, Spain
Jagiellońskie Centrum Innowacji Sp. z o.o.

Krakow, Poland
Laser Clinic S.C. dr Tomasz Kochanowski dr Andrzej Królicki

Szczecin, Poland
NZOZ Przychodnia Specjalistyczna "A-DERM-SERWIS"

Częstochowa, Poland
Specderm Poznanska Sp. j.

Bialystok, Poland
Twoja Przychodnia Szczecinskie Centrum Medyczne Sp. z o.o.

Szczecin, Poland
Universita Degli Studi Di Modena E Reggio Emilia

Modena, Italy
University Hospital Of Ferrara

Ferrara, Italy
Uniwersytecki Szpital Kliniczny Im.Fryderyka Chopina W Rzeszowie

Rzeszów, Poland
Uniwersyteckie Centrum Kliniczne

Gdansk, Poland
Velocity Nova Sp. z o.o.

Lublin, Poland
Vita Longa Sp. z o.o.

Katowice, Poland

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

N-Acetyl-GED-0507-34-LEVO gel 5%

What this could lead to

If it works, this could provide a new once-daily gel option to reduce acne breakouts on the face and upper body.

What could go wrong

This is a Phase 3 trial, but results are not yet known. The gel may not work better than placebo, and some users may experience skin irritation.

Conditions

The condition(s) this trial relates to.

acne Acne Vulgaris

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACNE VULGARIS ACNE VULGARIS